1009 related articles for article (PubMed ID: 19252675)
21. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.
Hariu H; Hirohashi Y; Torigoe T; Asanuma H; Hariu M; Tamura Y; Aketa K; Nabeta C; Nakanishi K; Kamiguchi K; Mano Y; Kitamura H; Kobayashi J; Tsukahara T; Shijubo N; Sato N
Clin Cancer Res; 2005 Feb; 11(3):1000-9. PubMed ID: 15709165
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
Kausch I; Jiang H; Thode B; Doehn C; Krüger S; Jocham D
Eur Urol; 2005 May; 47(5):703-9. PubMed ID: 15826766
[TBL] [Abstract][Full Text] [Related]
23. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of GADD45A enhances chemosensitivity in melanoma.
Liu J; Jiang G; Mao P; Zhang J; Zhang L; Liu L; Wang J; Owusu L; Ren B; Tang Y; Li W
Sci Rep; 2018 Mar; 8(1):4111. PubMed ID: 29515153
[TBL] [Abstract][Full Text] [Related]
25. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
[TBL] [Abstract][Full Text] [Related]
26. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.
Sasaki H; Sheng Y; Kotsuji F; Tsang BK
Cancer Res; 2000 Oct; 60(20):5659-66. PubMed ID: 11059757
[TBL] [Abstract][Full Text] [Related]
28. Icariside II induces apoptosis of melanoma cells through the downregulation of survival pathways.
Wu J; Xu J; Eksioglu EA; Chen X; Zhou J; Fortenbery N; Wei S; Dong J
Nutr Cancer; 2013; 65(1):110-7. PubMed ID: 23368920
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-Platin.
Agudo-López A; Prieto-García E; Alemán J; Pérez C; Díaz-García CV; Parrilla-Rubio L; Cabrera S; Navarro-Ranninger C; Cortés-Funes H; López-Martín JA; Agulló-Ortuño MT
Mol Cancer; 2017 Feb; 16(1):45. PubMed ID: 28231799
[TBL] [Abstract][Full Text] [Related]
30. Antisurvivin oligonucleotides inhibit growth and induce apoptosis in human medullary thyroid carcinoma cells.
Du ZX; Zhang HY; Gao DX; Wang HQ; Li YJ; Liu GL
Exp Mol Med; 2006 Jun; 38(3):230-40. PubMed ID: 16819281
[TBL] [Abstract][Full Text] [Related]
31. Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells.
Nomura T; Yamasaki M; Nomura Y; Mimata H
Oncol Rep; 2005 Oct; 14(4):993-7. PubMed ID: 16142363
[TBL] [Abstract][Full Text] [Related]
32. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
Yang BF; Xiao C; Li H; Yang SJ
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862
[TBL] [Abstract][Full Text] [Related]
33. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
34. Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell lines.
Smith CS; Golubovskaya VM; Peck E; Xu LH; Monia BP; Yang X; Cance WG
Melanoma Res; 2005 Oct; 15(5):357-62. PubMed ID: 16179862
[TBL] [Abstract][Full Text] [Related]
35. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of different sequences of radio- and chemotherapy in experimental models of human melanoma.
Arienti C; Zoli W; Pignatta S; Carloni S; Paganelli G; Ulivi P; Romeo A; Menghi E; Sarnelli A; Medri L; Polico R; Silvestrini R; Tesei A
J Cell Physiol; 2014 Oct; 229(10):1548-56. PubMed ID: 24591063
[TBL] [Abstract][Full Text] [Related]
37. Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins.
Li J; Feng Q; Kim JM; Schneiderman D; Liston P; Li M; Vanderhyden B; Faught W; Fung MF; Senterman M; Korneluk RG; Tsang BK
Endocrinology; 2001 Jan; 142(1):370-80. PubMed ID: 11145600
[TBL] [Abstract][Full Text] [Related]
38. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
39. Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma.
Gordon GJ; Appasani K; Parcells JP; Mukhopadhyay NK; Jaklitsch MT; Richards WG; Sugarbaker DJ; Bueno R
Carcinogenesis; 2002 Jun; 23(6):1017-24. PubMed ID: 12082024
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
